Rebecca Fischer-Betz

TL;DR: Compatibility with pregnancy and lactation was found for antimalarials, sulfasalazine, azathioprine, ciclosporin, tacrolimus, colchicine, intravenous immunoglobulin and glucocorticoids, and tumour necrosis factor inhibitors.

TL;DR: Recommendations for women's health issues in SLE and/or APS were developed using an evidence-based approach followed by expert consensus.

TL;DR: An international task force of 60 specialists and patient representatives agreed on eight key statements regarding remission in SLE and three principles to guide the further development of remission definitions, which provides a framework for testing different definitions of remission against long-term outcomes.

TL;DR: Data from this registry indicate that rituximab is a commonly employed, well-tolerated therapy with potential beneficial effects in standard of care-refractory autoimmune diseases, and support the results from other open-label, uncontrolled studies.

TL;DR: These are the first response criteria in any disease where a clinically relevant change has been determined a priori and mapped to standardized measures and should aid the clinical evaluation of new therapies, improve comparability between trials, and facilitate innovative trial designs.